• Welcome and Introduction
• Overview of CAR T-Cell Therapy
• CAR T-Cell Therapy for Multiple Myeloma
• Toxicity Management
• Audience Question and Answer Session
Date / Time
Amrita Krishnan, MD
Director, Judy and Bernard Briskin Center for Multiple Myeloma Research
City of Hope
Nikhil Munshi, MD
Professor of Medicine, Harvard Medical School
Director of Basic and Correlative Science
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
The goal of this activity is to improve the knowledge, competence, and performance of physicians and other healthcare professionals so they can confidently and competently integrate CAR T-cell therapy into their clinical practices.
This program is intended for physicians and other healthcare professionals who care for patients with multiple myeloma.
Upon completion of this activity, participants should be able to:
- Identify patients with multiple myeloma who are likely to benefit from CAR T-cell therapy or are eligible for clinical trial enrollment
- Integrate into practice clinical trial data on CAR T-cell–based therapies for the treatment of patients with multiple myeloma
- Manage toxicities associated with CAR T-cell therapy using available guidelines and online clinical resources and tools
- Implement strategies to educate patients eligible for this treatment about the potential for these complications
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.